Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT

Immuneering Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-15.05M -18.05M -14.6M -14.08M -14.31M -15.08M -12.6M -12.19M -13.6M -13.25M -12.84M -11.53M -12.9M -10.78M -8.53M -7.99M -6.23M
Depreciation & Amortization
92.58K 174.65K 96.27K 97.85K 187.68K 97.07K 85.61K -20.23K 189.63K 189.28K 204.53K -82.94K 200.63K 52.5K 37.57K 35.11K 33.89K
Stock-Based Compensation
1.69M 1.72M 1.64M 1.66M 1.47M 1.64M 1.48M 1.33M 1.27M 1.05M 1.07M 1.05M 897.65K 632.58K 636.81K 351.01K 182.22K
Other Working Capital
-215K 1.64M 21.86K 331.31K -2.8M 1.71M -16.48K 94.34K -1.67M -400.24K -158.68K 1.08M -800.92K 1.05M 148.04M 1.1M 29.42M
Other Non-Cash Items
83.18K -50.22K 46.55K 69.92K 1.57M -313.03K -822K 99.55K -186.3K -214.19K -96.46K -220.73K 103.53K 13.33M 8.55K 360.21K 354.05K
Deferred Income Tax
n/a n/a n/a n/a n/a -620.19K 620.19K n/a n/a n/a n/a n/a n/a -13.51M n/a n/a n/a
Change in Working Capital
-903K 1.69M -657.59K 724.49K -2.68M 1.88M -794.68K 27.06K -2.09M 473.7K 1.05M 782.34K -586.47K 1.05M -1.18M 1.16M -126.31K
Operating Cash Flow
-14.08M -14.51M -13.47M -11.53M -15.49M -11.78M -12.03M -10.75M -14.42M -11.75M -10.62M -9.45M -12.28M -9.24M -9.03M -6.44M -6.14M
Capital Expenditures
-8.95K -9.36K -5.27K -32.77K -37.48K -170.92K -57.15K -86.69K -27.99K -69.3K -393.13K -165K -115.05K -13.05K -11.35K -19.82K -16.56K
Cash Acquisitions
n/a n/a n/a n/a n/a -3.3M 23.91M n/a n/a -41.83M 486.94K n/a n/a 70.35K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a -15.75M -28.91M n/a n/a -12.38M -19.74M -10.01M -7.98M -22.87M -52.76M n/a n/a
Sales Maturities Of Investments
n/a 5.5M n/a 5M 21.43M 19.05M 5M 9.25M 19M 20.6M 19.25M 32.33M 20.5M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -5.41M n/a 21.43M 3.3M -23.91M 9.25M 19M 41.83M -486.94K 22.32M 12.52M 70.35K -52.76M n/a n/a
Investing Cash Flow
-8.95K 5.49M -5.42M 4.97M 21.39M 3.13M -23.97M 9.16M 18.97M 8.15M -880.08K 22.15M 12.4M -22.81M -52.77M -19.82K -16.56K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
133.89K -40.99K 127.19K n/a 979.92K 7.83K 21.45K 28.17M 239.41K -184.68K -17.21K 27.78K 193.11K 7.52K 118.49M 979.75K n/a
Financial Cash Flow
13.81M -40.99K 4.36M n/a 979.92K 7.83K 21.45K 28.17M 239.41K -184.68K -17.21K 27.78K 193.11K 7.52K 118.49M 25.77M n/a
Net Cash Flow
-279K -9.06M -14.52M -6.56M 6.88M -8.63M -35.98M 26.59M 4.79M -3.78M -11.52M 12.73M 316.92K -32.04M 56.68M 19.31M -6.16M
Free Cash Flow
-14.09M -14.52M -13.48M -11.56M -15.53M -11.95M -12.08M -10.84M -14.45M -11.82M -11.02M -9.61M -12.4M -9.25M -9.05M -6.46M -6.16M